Page last updated: 2024-11-03

primaquine and Aphasia

primaquine has been researched along with Aphasia in 1 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Aphasia: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hill, GJ1
Knight, V1
Coatney, GR1
Lawless, DK1

Other Studies

1 other study available for primaquine and Aphasia

ArticleYear
Vivax malaria complicated by aphasia and hemiparesis.
    Archives of internal medicine, 1963, Volume: 112, Issue:6

    Topics: Adult; Aphasia; Body Temperature; Cerebrovascular Disorders; Chloroquine; Hematocrit; Hemiplegia; Hu

1963